POSTER SESSION IV Tuesday, March 9, 2004   —  1:00 - 4:30 PM Exhibit Hall B and C HEMATOPATHOLOGY 117 Expression of Nucleoside Transporters, hENT1 and hCNT3 in Precursor B-Cell Acute Lymphoblastic Leukemia (1127) EJ Schlette, DD Glubrecht, L Dabbagh, R Lai, J Mackey - M.D. Anderson Cancer Center, Houston, TX; Cross Cancer Institute and University of Alberta, Edmonton, AB, Canada 118 Flow Cytometric Immunophenotyping and Cytogenetic Analysis of Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL): Correlation with Short-Term Treatment Outcomes (1030) M Cushing, S Li - Emory University, Atlanta, GA 119 Flow Cytometric Immunophenotyping and Cytogenetic Analysis of Acute Myeloid Leukemia (AML) at Diagnosis and Relapse (1031) M Cushing, S Li - Emory University, Atlanta, GA 120 Stability of Leukemia-Associated Immunophenotypes in Precursor B-Cell Acute Lymphoblastic Leukemia: A Single Institution Experience (1023) W Chen, NJ Karandikar, RW McKenna, SH Kroft - University of Texas Southwestern Medical School, Dallas, TX 121 Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL) with MLL Gene Rearrangement: A Distinct Subset of B-ALL (1153) L Tsao, HD Draoua, SV Nandula, S Murty, M Mansukhani, G Bhagat, B Alobeid - Columbia University, New York, NY 122 A Myeloid Leukemia Cell Line Susceptible to Diepoxybutane (DEB) (1070) Y Kao, R McGoey, L Lyall - Louisiana State University Health Sciences Center, New Orleans, LA 123 Podocalyxin Expression in Acute Leukemia (1071) TW Kelley, D Huntsman, KM McNagny, CD Roskelley, ED Hsi - Cleveland Clinic Foundation, Cleveland, OH; University of British Columbia, Vancouver, BC, Canada 124 Expression of Regulatory Cell Cycle Proteins p53, p21, p27, p14, p16, mdm2 and Cyclin E, in De Novo Acute Myeloid Leukemia (1168) V Zolota, C Sirinian, M Melachrinou, DS Bonikos - University of Patras School of Medicine, Patras Greece 125 Adhesion Protein Expression on Acute Myelogenous Leukemia (AML) Blasts Correlates with Morphologic Subtype and Percentage of Circulating Blasts (1162) JJ Wu, A Cantor, L Moscinski - University of South Florida College of Medicine, Tampa, FL 126 Expression of Constitutively Active Nuclear-kB Rela Transcription Factor in Blasts of Acute Myeloid Leukemia (1016) CE Bueso-Ramos, FC Rocha, S Shishodia, LJ Medeiros, HM Kantarjian, S Vadhan-Raj, Z Estrov, BB Aggarwal - The University of Texas MD Anderson Cancer Center, Houston, TX 127 Development and Validation of a Q-RT-PCR Assay for PML/RARa Transcripts in Acute Promyelocytic Leukemia Patients (1062) Q Huang, K Gaal, ML Slovak, S Alkan, KL Chang - City of Hope National Medical Center, Duarte, CA; Loyola University Medical Center, Maywood, IL 128 Differentiating Acute Promyelocytic Leukemia from Growth Factor-Associated Reactive Proliferations Using Paraffin Section Immunophenotyping (1048) TI George, RA Warnke, DA Arber - Stanford University Medical Center, Dept. of Pathology, Stanford, CA 129 Application of World Health Organization (WHO) Criteria to the Classification of Myeloproliferative and Myelodysplastic/Myeloproliferative Diseases (1045) CF Garcia, A Galan, JK Freeman, RP Hasserjian - Massachusetts General Hospital, Boston, MA; Baystate Medical Center, Springfield, MA 130 Evaluation of Mast Cells in Myeloproliferative Disorders and Myelodysplastic Syndromes (1037) CH Dunphy - University of North Carolina, Chapel Hill, NC 131 Comparison of Flow Cytometric Immunophenotypic (FCI) Findings in Acute Monocytic Leukemia (AMoL), Chronic Myelomonocytic Leukemia (CMML), and Normal Monocytes (1036) CH Dunphy, SM Orton, JL Mantell - University of North Carolina, Chapel Hill, NC 132 Immunoreactivity of MIC2(CD99) and Terminal Deoxytransferase(TdT) In Bone Marrow(BM) Clot and Core Specimens of Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS) (1069) LC Kang, CH Dunphy - University of North Carolina, Chapel Hill, NC 133 Myelodysplastic Syndrome and Acute Myeloid Leukemia Associated with Philadelphia Chromosome - A Distinct Entity? (1011) MW Beaty, BL Powell, I Molnar, D Buss, M Pettenati, YK Keung - Wake Forest University School of Medicine, Winston-Salem, NC 134 Progression of Chronic Myeloid Leukemia (CML) from Chronic Phase To Blast Crisis during Treatment with Imatinib Mesylate: A Report of Three Cases (1163) Y Xu, AE Wahner, PL Nguyen - University of Minnesota Medical School, Minneapolis, MN 135 Inversion Chromosome 16 in Blast Phase of Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia: A Case Report and Review of the Literature (1090) R McGoey, G Lipscomb, Y Kao - Medical Center of Louisiana, New Orleans, LA